Treatment for Bipolar Disorder now available in Nova Scotia Formulary
TORONTO, April 20 /CNW/ - The Nova Scotia Department of Health and
Wellness has approved the listing of LITHMAX (Lithium Carbonate
Sustained-Release 300mg Tablets) in the Nova Scotia Formulary,
effective April 19th, 2011. This announcement comes as welcome news to
patients in need of the sustained-release formulation of Lithium
Carbonate who require help to pay for prescribed medications. LITHMAX
is indicated for the treatment of manic episodes of Bipolar Disorder,
as well as the maintenance treatment for individuals with a diagnosis
of Bipolar Disorder. This extended-release formulation, only available
from AA Pharma Inc., has been available in drugstores across Canada
since January 2011, and scheduled to be on all provincial formulary
lists by the end of 2011, making LITHMAX a cost effective treatment
option for Bipolar 1 and 2.
The extended-release formulation comes as exciting news to both patients
and physicians of the Canadian mental health community because of the
long absence of this formulation in the market. This formulation
enables patients taking lithium to obtain peak plasma levels at about
50% lower than immediate release and subsequently experience far less
side effects. In addition to this, there are far better continuous
blood levels, making LITHMAX the drug of choice for Bipolar 1 and 2.
"We have worked very hard to make this formulation available in
Canada", explains Norman Paul, President of AA Pharma Inc. The clinical
consequence of the unavailability of Lithium Carbonate SR 300mg in
Canada has meant that up until now many patients have had difficulty in
maintaining good health. For more information about LITHMAX visit www.lithmax.ca.
About AA Pharma Inc.:
AA Pharma Inc. is a privately owned Canadian Pharmaceutical Company that
is aggressively acquiring products to meet the needs of the Canadian
healthcare market. AA Pharma Inc. is currently shipping an assortment
of over 50 drugs in a variety of convenient strengths that are
available at all drug wholesalers across Canada.
SOURCE AA Pharma Inc.
For further information:
Norman Paul, BScPh
AA Pharma Inc.